Drug · DIN 02266695
LITHMAX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 14, 2011; first marketed April 6, 2005.
- Drug Identification Number (DIN)
- 02266695
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Lithium N05AN01
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LITHIUM CARBONATE | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 19, 2010: NOC 11875Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- November 23, 2005: NOC 6371Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage form